| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-10 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |